Manulife Multifactor Developed International Index ETF (TSX:MINT.B)
Assets | 541.61M |
Expense Ratio | 0.50% |
PE Ratio | n/a |
Dividend (ttm) | 0.86 |
Dividend Yield | 2.35% |
Ex-Dividend Date | May 14, 2025 |
Payout Frequency | Semi-Annual |
Payout Ratio | n/a |
1-Year Return | +9.10% |
Volume | 700 |
Open | 37.13 |
Previous Close | 36.74 |
Day's Range | 37.13 - 37.15 |
52-Week Low | 32.01 |
52-Week High | 37.45 |
Beta | 0.98 |
Holdings | 595 |
Inception Date | Apr 17, 2017 |
About MINT.B
Manulife Multifactor Developed International Index ETF is an exchange traded fund launched and managed by Manulife Investment Management Limited. The fund is co-managed by Dimensional Fund Advisors Canada ULC. It invests in public equity markets of global ex-US/Canada region. It invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the John Hancock Dimensional Developed International Index (CAD), by using full replication technique. Manulife Multifactor Developed International Index ETF was formed on March 23, 2017 and is domiciled in Canada.
Performance
MINT.B had a total return of 9.10% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.42%.
Top 10 Holdings
11.48% of assetsName | Symbol | Weight |
---|---|---|
Vinci SA | DG | 1.72% |
Novartis AG | NOVN | 1.57% |
Shell plc | SHEL | 1.34% |
TotalEnergies SE | TTE | 1.20% |
ASML Holding N.V. | ASML | 1.04% |
Nestlé S.A. | NESN | 0.98% |
Novo Nordisk A/S | NOVO.B | 0.97% |
BNP Paribas SA | BNP | 0.91% |
Deutsche Telekom AG | DTE | 0.89% |
Danone S.A. | BN | 0.86% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
May 14, 2025 | 0.31117 CAD | May 28, 2025 |
Dec 30, 2024 | 0.33238 CAD | Jan 14, 2025 |
Jun 28, 2024 | 0.52843 CAD | Jul 12, 2024 |
Dec 28, 2023 | 0.37033 CAD | Jan 12, 2024 |
Jun 29, 2023 | 0.50369 CAD | Jul 13, 2023 |
Dec 29, 2022 | 0.28327 CAD | Jan 13, 2023 |